Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03831282 · ClinicalTrials.gov registry record · NA
Feasibility and Performance Evaluation of INVSENSOR00024
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03831282 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 12 participants.
The verdict
NCT03831282, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized, single arm study design to evaluate SpO2 performance of the INVSENSOR00024 sensors in the neonatal population in a clinical environment using convenience sampling.
Interventions
- DEVICE RD SET Neo SpO2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2019-05-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03831282
The ClinicalTrials.gov registry entry for NCT03831282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RD SET Neo SpO2 is the first listed.
NCT03831282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03831282 about?
NCT03831282 is a clinical study titled "Feasibility and Performance Evaluation of INVSENSOR00024". This is a prospective, non-randomized, single arm study design to evaluate SpO2 performance of the INVSENSOR00024 sensors in the neonatal population in a clinical environment using convenience sampling.
What is the current status of trial NCT03831282?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-02-08. Estimated completion is 2019-05-28.
What interventions are being tested in trial NCT03831282?
The interventions under investigation include: RD SET Neo SpO2 (DEVICE).
Who is sponsoring clinical trial NCT03831282?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.